Cargando…

Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer

PURPOSE: Ovarian cancer is the leading cause of gynecologic cancer-related death worldwide. Early diagnosis of ovarian cancer can significantly improve patient prognosis. Hence, there is an urgent need to identify key diagnostic and prognostic biomarkers specific for ovarian cancer. Because high-gra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Si, Manfei, Zhang, Junji, Cao, Jianzhong, Xie, Zhibo, Shu, Shan, Zhu, Yapei, Lang, Jinghe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877452/ https://www.ncbi.nlm.nih.gov/pubmed/31819501 http://dx.doi.org/10.2147/OTT.S228678

Ejemplares similares

Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer
por: Hu, Yingchao, et al.
Publicado: (2019)

The roles of metallothioneins in carcinogenesis
por: Si, Manfei, et al.
Publicado: (2018)

Integrated weighted gene co‐expression network analysis reveals biomarkers associated with prognosis of high‐grade serous ovarian cancer
por: Wang, Bo, et al.
Publicado: (2022)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
por: Hunter, Sally M., et al.
Publicado: (2015)

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer
por: Dutt, Mriga, et al.
Publicado: (2023)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer
por: Lu, Haonan, et al.
Publicado: (2021)

Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas
por: Machino, Hidenori, et al.
Publicado: (2023)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
por: Cheasley, Dane, et al.
Publicado: (2022)

CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
por: Wheeler, Lindsay J., et al.
Publicado: (2018)

Identifying high-grade serous ovarian carcinoma–specific extracellular vesicles by polyketone-coated nanowires
por: Yokoi, Akira, et al.
Publicado: (2023)

Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers
por: Kamble, Swapnil C., et al.
Publicado: (2019)

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021)

AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
por: Hojnik, Marko, et al.
Publicado: (2022)

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
por: Ducie, Jennifer, et al.
Publicado: (2017)

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer
por: Cardillo, Nicholas, et al.
Publicado: (2022)

Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
por: Crispin-Ortuzar, Mireia, et al.
Publicado: (2023)

Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
por: Topno, Rachel, et al.
Publicado: (2021)

Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
por: Gross, Amy L., et al.
Publicado: (2010)

Molecular classification and immunologic characteristics of immunoreactive high‐grade serous ovarian cancer
por: Liu, Zheran, et al.
Publicado: (2020)

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
por: Lee, Sanghoon, et al.
Publicado: (2020)

Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging
por: Kassuhn, Wanja, et al.
Publicado: (2021)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
por: Ribeiro e Ribeiro, Renan, et al.
Publicado: (2021)

The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012)

Trends of low-grade serous ovarian carcinoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

High grade serous ovarian carcinomas originate in the fallopian tube
por: Labidi-Galy, S. Intidhar, et al.
Publicado: (2017)

Spatially resolved transcriptomics of high-grade serous ovarian carcinoma
por: Stur, Elaine, et al.
Publicado: (2022)

Principles of dormancy evident in high-grade serous ovarian cancer
por: Shepherd, Trevor G., et al.
Publicado: (2022)

Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers
por: Azzalini, Eros, et al.
Publicado: (2023)

MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
por: Li, Hai Ming, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_73rt39k8kdijuq0peupaetremj